Journal of Antimicrobial Chemotherapy (2000) 45, 395-400
© 2000 The British Society for Antimicrobial Chemotherapy
Antimicrobial practice |
Non-hospital consumption of antibiotics in Spain: 1987–1997
a Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Sinesio Delgado 6, 28029 Madrid, Spain; b Niño Jesús Children's Teaching Hospital; c Sub-Directorate General for Drug Regulation, Ministry of Health and Consumer Affairs
Abstract
Spain has one of the highest incidences of bacterial resistance to antimicrobials, possibly linked to drug consumption patterns. Using Ministry of Health and Consumer Affairs records, data were obtained on non-hospital sales of antibiotics for the period 1987–1997, and equivalents calculated in weight of active drug ingredient and defined daily doses per 1000 population per day (DDD/1000/day). The number of packages sold declined from 75 million in 1987 to 55 million in 1997. None the less, there was a gradual yet steady rise in consumption in tonnage terms (249 to 275 tonnes). Furthermore, in terms of DDD/1000/day, consumption rose sharply until 1995 and then held steady at 21 DDD/1000/day, a level comparable to the mean for other developed countries. Penicillins were the group to register the highest consumption in Spain, followed—in the latter years of the study—by macrolides, cephalosporins and quinolones. The marked rise in these latter three groups was noteworthy. Despite the decrease in the number of packages sold, antibiotic consumption in Spain has risen. This consumption pattern is different from that of other European countries and might serve to explain differences in the generation of resistance.
Notes
* Corresponding author. Tel: +34-91-387-78-02; Fax: +34-91-387-78-15; E-mail: mruiz{at}isciii.es
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Oteo, E. Lazaro, F. J. de Abajo, F. Baquero, J. Campos, and Spanish Members of the European Antimicrobial Resi Trends in Antimicrobial Resistance in 1,968 Invasive Streptococcus pneumoniae Strains Isolated in Spanish Hospitals (2001 to 2003): Decreasing Penicillin Resistance in Children's Isolates J. Clin. Microbiol., December 1, 2004; 42(12): 5571 - 5577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Mitema and G. M. Kikuvi Surveillance of the overall use of antimicrobial drugs in humans over a 5 year period (1997-2001) in Kenya J. Antimicrob. Chemother., November 1, 2004; 54(5): 966 - 967. [Full Text] [PDF]
|
|
|
|
|
|
M. Perez-Vazquez, F. Roman, B. Aracil, R. Canton, and J. Campos Laboratory Detection of Haemophilus influenzae with Decreased Susceptibility to Nalidixic Acid, Ciprofloxacin, Levofloxacin, and Moxifloxacin Due to gyrA and parC Mutations J. Clin. Microbiol., March 1, 2004; 42(3): 1185 - 1191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Campos, M. Hernando, F. Roman, M. Perez-Vazquez, B. Aracil, J. Oteo, E. Lazaro, F. de Abajo, and the Group of Invasive Haemophilus Infections of th Analysis of Invasive Haemophilus influenzae Infections after Extensive Vaccination against H. influenzae Type b J. Clin. Microbiol., February 1, 2004; 42(2): 524 - 529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Alarcon, A. E. Vega, D. Domingo, M. J. Martinez, and M. Lopez-Brea Clarithromycin Resistance among Helicobacter pylori Strains Isolated from Children: Prevalence and Study of Mechanism of Resistance by PCR-Restriction Fragment Length Polymorphism Analysis J. Clin. Microbiol., January 1, 2003; 41(1): 486 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Oteo, J. Campos, F. Baquero, and Spanish members of the European Antimicrobial Resi Antibiotic resistance in 1962 invasive isolates of Escherichia coli in 27 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System (2001) J. Antimicrob. Chemother., December 1, 2002; 50(6): 945 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vaccheri, L. Bjerrum, D. Resi, U. Bergman, and N. Montanaro Antibiotic prescribing in general practice: striking differences between Italy (Ravenna) and Denmark (Funen) J. Antimicrob. Chemother., December 1, 2002; 50(6): 989 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Dancer The problem with cephalosporins J. Antimicrob. Chemother., October 1, 2001; 48(4): 463 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. de Neeling, B. P. Overbeek, A. M. Horrevorts, E. E. J. Ligtvoet, and W. G. Goettsch Antibiotic use and resistance of Streptococcus pneumoniae in The Netherlands during the period 1994-1999 J. Antimicrob. Chemother., September 1, 2001; 48(3): 441 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Chopra and M. Roberts Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance Microbiol. Mol. Biol. Rev., June 1, 2001; 65(2): 232 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cizman, M. Pokorn, K. Seme, A. Orazem, and M. Paragi The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens J. Antimicrob. Chemother., April 1, 2001; 47(4): 475 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cizman, A. Orazem, V. Krizan-Hergouth, and J. Kolman Correlation between increased consumption of fluoroquinolones in outpatients and resistance of Escherichia coli from urinary tract infections J. Antimicrob. Chemother., April 1, 2001; 47(4): 502 - 502. [Full Text] [PDF]
|
|